321 related articles for article (PubMed ID: 33291603)
1. Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment.
Vivarelli S; Candido S; Caruso G; Falzone L; Libra M
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291603
[TBL] [Abstract][Full Text] [Related]
2. Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy.
Mei J; Liu X; Tian HX; Chen Y; Cao Y; Zeng J; Liu YC; Chen Y; Gao Y; Yin JY; Wang PY
Clin Transl Med; 2024 Apr; 14(4):e1656. PubMed ID: 38664597
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response.
Kim S; Choung S; Sun RX; Ung N; Hashemi N; Fong EJ; Lau R; Spiller E; Gasho J; Foo J; Mumenthaler SM
SLAS Discov; 2020 Aug; 25(7):744-754. PubMed ID: 32349587
[TBL] [Abstract][Full Text] [Related]
4. Clinical translation of patient-derived tumour organoids- bottlenecks and strategies.
Foo MA; You M; Chan SL; Sethi G; Bonney GK; Yong WP; Chow EK; Fong ELS; Wang L; Goh BC
Biomark Res; 2022 Mar; 10(1):10. PubMed ID: 35272694
[TBL] [Abstract][Full Text] [Related]
5. The landscape of drug sensitivity and resistance in sarcoma.
Al Shihabi A; Tebon PJ; Nguyen HTL; Chantharasamee J; Sartini S; Davarifar A; Jensen AY; Diaz-Infante M; Cox H; Gonzalez AE; Swearingen S; Tavanaie N; Dry S; Singh A; Chmielowski B; Crompton JG; Kalbasi A; Eilber FC; Hornicek F; Bernthal N; Nelson SD; Boutros PC; Federman N; Yanagawa J; Soragni A
bioRxiv; 2023 Aug; ():. PubMed ID: 37292676
[TBL] [Abstract][Full Text] [Related]
6. Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer.
Grützmeier SE; Kovacevic B; Vilmann P; Rift CV; Melchior LC; Holmström MO; Brink L; Hassan H; Karstensen JG; Grossjohann H; Chiranth D; Toxværd A; Hansen CP; Høgdall E; Hasselby JP; Klausen P
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509338
[TBL] [Abstract][Full Text] [Related]
7. Culture of patient-derived multicellular clusters in suspended hydrogel capsules for pre-clinical personalized drug screening.
Dong H; Li Z; Bian S; Song G; Song W; Zhang M; Xie H; Zheng S; Yang X; Li T; Song P
Bioact Mater; 2022 Dec; 18():164-177. PubMed ID: 35387168
[TBL] [Abstract][Full Text] [Related]
8. Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids.
Charpentier M; Bloy N; Formenti SC; Galluzzi L; Demaria S
J Vis Exp; 2024 Apr; (206):. PubMed ID: 38647326
[TBL] [Abstract][Full Text] [Related]
9. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing in Oncology: Current Evidence and Future Direction.
Zhang Z; Ji J; Liu H
Curr Med Chem; 2021; 28(11):2175-2194. PubMed ID: 33109032
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of patient-derived tumor organoids generation from malignant effusions.
Seghers S; Le Compte M; Hendriks JMH; Van Schil P; Janssens A; Wener R; Komen N; Prenen H; Deben C
Crit Rev Oncol Hematol; 2024 Mar; 195():104285. PubMed ID: 38311013
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis.
Le Compte M; Cardenas De La Hoz E; Peeters S; Smits E; Lardon F; Roeyen G; Vanlanduit S; Prenen H; Peeters M; Lin A; Deben C
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36622028
[TBL] [Abstract][Full Text] [Related]
13. Cutoff value of IC
Tang Y; Wang T; Hu Y; Ji H; Yan B; Hu X; Zeng Y; Hao Y; Xue W; Chen Z; Lan J; Wang Y; Deng H; Deng C; Wu X; Yan J
iScience; 2023 Jul; 26(7):107116. PubMed ID: 37426352
[TBL] [Abstract][Full Text] [Related]
14. The promises and challenges of patient-derived tumor organoids in drug development and precision oncology.
Granat LM; Kambhampati O; Klosek S; Niedzwecki B; Parsa K; Zhang D
Animal Model Exp Med; 2019 Sep; 2(3):150-161. PubMed ID: 31773090
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of a living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models].
Pauli C; Moch H; Rubin MA
Pathologe; 2017 Nov; 38(Suppl 2):160-168. PubMed ID: 28956107
[TBL] [Abstract][Full Text] [Related]
16. Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery.
Weeber F; Ooft SN; Dijkstra KK; Voest EE
Cell Chem Biol; 2017 Sep; 24(9):1092-1100. PubMed ID: 28757181
[TBL] [Abstract][Full Text] [Related]
17. Tumor organoids: From inception to future in cancer research.
Yang L; Yang S; Li X; Li B; Li Y; Zhang X; Ma Y; Peng X; Jin H; Fan Q; Wei S; Liu J; Li H
Cancer Lett; 2019 Jul; 454():120-133. PubMed ID: 30981763
[TBL] [Abstract][Full Text] [Related]
18. Living biobank-based cancer organoids: prospects and challenges in cancer research.
Li H; Liu H; Chen K
Cancer Biol Med; 2022 Jul; 19(7):965-82. PubMed ID: 35856555
[TBL] [Abstract][Full Text] [Related]
19. "Tissues in a Dish": A Review of Organoids in Plastic Surgery.
Chinta MS; desJardins-Park HE; Wan DC; Longaker MT
Plast Reconstr Surg Glob Open; 2020 Apr; 8(4):e2787. PubMed ID: 32440447
[TBL] [Abstract][Full Text] [Related]
20. Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms.
Alcala N; Voegele C; Mangiante L; Sexton-Oates A; Clevers H; Fernandez-Cuesta L; Dayton TL; Foll M
Gigascience; 2024 Jan; 13():. PubMed ID: 38451475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
